A Phase 2 trial, run by McMaster University, of an inhaled COVID-19 vaccine is starting; they are looking for participants in Hamilton, Ottawa, and Halifax. The eligibility details are in the press release:
Dieser Beitrag wurde bearbeitet. (3 Wochen her)